ArticleSchizophrenia bulletin2022

Reducing the Risk of Withdrawal Symptoms and Relapse Following Clozapine Discontinuation-Is It Feasible to Develop Evidence-Based Guidelines?

Graham Blackman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.